SP
IPSC icon

Syncona Portfolio’s Century Therapeutics IPSC Stock Holding History

Syncona Portfolio’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,213,056
Closed -$2.74M – 2
2026
Q1 		$2.74M Hold
1,213,056
– – 10.67% 2
2025
Q4 		$1.21M Hold
1,213,056
– – 3.52% 2
2025
Q3 		$604K Hold
1,213,056
– – 2.18% 2
2025
Q2 		$678K Hold
1,213,056
– – 1.76% 2
2025
Q1 		$577K Hold
1,213,056
– – 2.19% 2
2024
Q4 		$1.23M Hold
1,213,056
– – 2.31% 3
2024
Q3 		$2.07M Buy
1,213,056
+212,285
+21% +$416K 2.57% 3
2024
Q2 		$2.55M Buy
+1,000,771
New +$3.16M 2.97% 3

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Syncona Portfolio's IPSC Position: Q2 2026 in Review

Syncona Portfolio sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 1,213,056 shares — an estimated $2.74M sold.

Syncona Portfolio first reported a position in IPSC in Q2 2024 and held it in 8 quarters. The position peaked at $2.74M in Q1 2026. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Syncona Portfolio reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Syncona Portfolio sold 1,213,056 Century Therapeutics shares in Q2 2026, an estimated $2.74M.
  • Syncona Portfolio first reported a position in Century Therapeutics in Q2 2024 and held it in 8 quarters.
  • Syncona Portfolio's Century Therapeutics position peaked at $2.74M in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Syncona Portfolio's 13F filing for Q2 2026, filed 7 Aug 2026.